AR016128A1 - Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento. - Google Patents

Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento.

Info

Publication number
AR016128A1
AR016128A1 ARP980103371A ARP980103371A AR016128A1 AR 016128 A1 AR016128 A1 AR 016128A1 AR P980103371 A ARP980103371 A AR P980103371A AR P980103371 A ARP980103371 A AR P980103371A AR 016128 A1 AR016128 A1 AR 016128A1
Authority
AR
Argentina
Prior art keywords
same
beta
pharmaceutical composition
production
acronym
Prior art date
Application number
ARP980103371A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR016128A1 publication Critical patent/AR016128A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ARP980103371A 1997-07-11 1998-07-10 Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento. AR016128A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition

Publications (1)

Publication Number Publication Date
AR016128A1 true AR016128A1 (es) 2001-06-20

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103371A AR016128A1 (es) 1997-07-11 1998-07-10 Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento.

Country Status (26)

Country Link
EP (1) EP0996466A2 (fr)
JP (1) JP2002508003A (fr)
KR (1) KR20010021644A (fr)
CN (1) CN1262627A (fr)
AP (1) AP2000001728A0 (fr)
AR (1) AR016128A1 (fr)
AU (1) AU9340198A (fr)
BG (1) BG104119A (fr)
BR (1) BR9810996A (fr)
CA (1) CA2295822A1 (fr)
CO (1) CO4950552A1 (fr)
DZ (1) DZ2556A1 (fr)
EA (1) EA200000112A1 (fr)
GB (1) GB9714675D0 (fr)
HU (1) HUP0003074A3 (fr)
ID (1) ID24191A (fr)
IL (1) IL133869A0 (fr)
MA (1) MA24604A1 (fr)
NO (1) NO20000107L (fr)
OA (1) OA11276A (fr)
PE (1) PE99699A1 (fr)
PL (1) PL338017A1 (fr)
SK (1) SK72000A3 (fr)
TR (1) TR200000074T2 (fr)
WO (1) WO1999002142A2 (fr)
ZA (1) ZA986138B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942009D1 (de) 1998-10-15 2010-03-25 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (fr) 1999-10-29 2011-03-16 Euro-Celtique S.A. Formulations d'hydrocodone à liberation lente
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
WO2006030306A2 (fr) * 2004-09-17 2006-03-23 Neurocure Ltd Methodes et compositions pour le traitement du syndrome premenstruel (pms) et d'un trouble dysphorique premenstruel (pmdd)
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
EP0714663A3 (fr) * 1994-11-28 1997-01-15 Lilly Co Eli Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
PT759299E (pt) * 1995-08-16 2000-09-29 Lilly Co Eli Potenciacao da resposta de serotonina
EP0792649A1 (fr) * 1996-02-29 1997-09-03 Eli Lilly And Company Traitement de l'insomnie

Also Published As

Publication number Publication date
OA11276A (en) 2003-07-31
HUP0003074A3 (en) 2001-12-28
EA200000112A1 (ru) 2000-10-30
BR9810996A (pt) 2000-08-08
AU9340198A (en) 1999-02-08
HUP0003074A2 (hu) 2001-01-29
CA2295822A1 (fr) 1999-01-21
ID24191A (id) 2000-07-13
TR200000074T2 (tr) 2000-05-22
CO4950552A1 (es) 2000-09-01
WO1999002142A2 (fr) 1999-01-21
PL338017A1 (en) 2000-09-25
WO1999002142A3 (fr) 1999-04-15
ZA986138B (en) 2000-01-10
CN1262627A (zh) 2000-08-09
JP2002508003A (ja) 2002-03-12
BG104119A (en) 2000-12-29
EP0996466A2 (fr) 2000-05-03
NO20000107D0 (no) 2000-01-10
SK72000A3 (en) 2000-12-11
NO20000107L (no) 2000-01-10
MA24604A1 (fr) 1999-04-01
KR20010021644A (ko) 2001-03-15
GB9714675D0 (en) 1997-09-17
DZ2556A1 (fr) 2003-02-15
AP2000001728A0 (en) 2000-03-31
PE99699A1 (es) 1999-12-21
IL133869A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
BRPI0407993B8 (pt) compostos inibidores de p38 e composições farmacêuticas compreendendo os mesmos
ECSP056148A (es) Compuestos inmunosupresores y composiciones
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
WO2007050783A3 (fr) Fasudil en polytherapies pour traiter l'hypertension arterielle pulmonaire
UY28041A1 (es) Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial.
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
DK1626720T3 (da) 4-(2-Phenylsulfanyl-phenyl)-piperidinderivater som serotonin-genoptagelseshæmmer
NO20070124L (no) Nye disubstituerte fenylpiperidiner/piperaziner som modulatorer av dopamin neurotransmisjon
AR035782A1 (es) Amidas sustituidas de acido benzofuran-2-carboxilico, un procedimiento para su preparacion, las preparaciones farmaceuticas que las contienen y el uso de las mismas para preparar un medicamento
CO4950552A1 (es) Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b
NO20070914L (no) Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander
NZ336587A (en) Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter
IL165840A0 (en) Combination therapy wherein a serotonin reuptake inhibitor is used
NO20055206L (no) 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer
DE60201590D1 (de) Antidepressiv wirksame azaheterocyclymethyl-derivative von oxaheterocycyl-anellierten (1,4)-benzodioxanen
IS2425B (is) Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun
Zhan et al. Design, synthesis, biological evaluation, and molecular docking of novel benzopyran and phenylpyrazole derivatives as Akt inhibitors
ATE304016T1 (de) Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h- 6,9-dioxa-1,3-diazacyclopenta (a) naphthalin
NZ506893A (en) Paroxetine compositions adsorbed or absorbed by a solid carrier
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
BR0115276A (pt) Composições farmacêuticas, uso de pelo menos um dos compostos, compostos, e, processo para a preparação de uma composição farmacêutica
BR0314430A (pt) Derivados de cicloalquilamina antidepressiva dos benzodioxanos fundidos por heterociclo